KENALOG Side Effects

7013412-7 | Arthralgia, Injection Site Atrophy, Muscle Atrophy, Pain, Panic Attack, Weight Decreased
on Sep 20, 2010 Female patient from UNITED STATES , 48 years of age, weighting 119.0 lb, was diagnosed with upper respiratory tract infection and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, injection site atrophy, muscle atrophy, pain (What is pain?), panic attack, weight decreased. Kenalog dosage: Also On 25oct10;. During the same period patient was treated with SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), TYLENOL (View Tylenol Review and Tylenol Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

7013402-4 | Elbow Deformity, Fibromyalgia, Pigmentation Disorder, Rheumatoid Arthritis, Scleroderma, Systemic Lupus Erythematosus
Patient was taking Kenalog (View Usage). Patient had the following side effects: elbow deformity, fibromyalgia, pigmentation disorder, rheumatoid arthritis (What is rheumatoid arthritis?), scleroderma (What is scleroderma?), systemic lupus erythematosus on Sep 20, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, . Kenalog dosage: . During the same period patient was treated with MOBIC (1 Tab) (View Mobic Review and Mobic Label ), MIRALAX (View Miralax Review and Miralax Label ), DONNATAL (1 Tab As Needed Bid) (View Donnatal Review and Donnatal Label ), CHANTIX (View Chantix Review and Chantix Label ), VICODIN (1df:5-500mg) (View Vicodin Review and Vicodin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), VITAMIN E (1df:100unit) (View Vitamin E Review and Vitamin E Label ).

7012466-1 | Balance Disorder, Dysphagia, Dyspnoea, Feeling Abnormal, Frequent Bowel Movements, Tremor, Weight Increased
Adverse event was reported on Sep 20, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: 31mar08:80mg) . Location: UNITED STATES , 61 years of age, weighting 134.5 lb, After Kenalog was administered, patient had the following side effects: balance disorder, dysphagia, dyspnoea, feeling abnormal, frequent bowel movements, tremor, weight increased. During the same period patient was treated with NABUMETONE (2 X 5 Daily) (View Nabumetone Review and Nabumetone Label ), SOMA (At Bed Time) (View Soma Review and Soma Label ), HERBAL MIXTURE (View Herbal Mixture Review and Herbal Mixture Label ), MILK THISTLE (View Milk Thistle Review and Milk Thistle Label ), ECHINACEA (View Echinacea Review and Echinacea Label ), HAWTHORN BERRY EXTRACT (View Hawthorn Berry Extract Review and Hawthorn Berry Extract Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), OMNIPAQUE 140 (1 Df = 1-2ml Omnipaque 240 Contrast Injection) (View Omnipaque 140 Review and Omnipaque 140 Label ).

7010816-3 | Bone Pain, Chest Pain, Condition Aggravated, Contusion, Dizziness, Dry Skin, Dyspnoea, Dystonia, Erythema
on Sep 23, 2010 Female patient from UNITED STATES , 46 years of age, weighting 150.0 lb, was diagnosed with complex regional pain syndrome (What is complex regional pain syndrome?), chronic fatigue syndrome (What is chronic fatigue syndrome?), fibromyalgia, neuromyopathy and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, chest pain (What is chest pain?), condition aggravated, contusion, dizziness (What is dizziness?), dry skin, dyspnoea, dystonia (What is dystonia?), erythema. Kenalog dosage: Unk Unk Intradiscal. During the same period patient was treated with OXYCONTIN (20mg Tid Inj) (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.


6978391-7 | Haematochezia
on Sep 07, 2010 Female patient from UNITED STATES , 72 years of age, was diagnosed with gastrooesophageal reflux disease, osteopenia and was treated with Kenalog (View Usage). Patient had the following side effects: haematochezia. Kenalog dosage: 24 Hours After The Injection. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), PEPCID (View Pepcid Review and Pepcid Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), FORTICAL (View Fortical Review and Fortical Label ), LAMICTAL (View Lamictal Review and Lamictal Label ). Patient was hospitalized.

6971263-3 | Syringomyelia
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: syringomyelia (What is syringomyelia?) on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with neck pain and. Kenalog dosage: Injection. Patient was hospitalized.

6958570-5 | Injection Site Atrophy, Injection Site Haematoma
Adverse event was reported on Aug 30, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: 1 Injection 1 Time) was diagnosed with multiple allergies and. Location: UNITED STATES , 28 years of age, weighting 118.0 lb, Patient experienced the following unwanted or unexpected effects: injection site atrophy, injection site haematoma.

6937556-0 | Hyperhidrosis, Insomnia, Night Sweats, Sleep Apnoea Syndrome
on Aug 23, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with intervertebral disc protrusion and was treated with Kenalog (View Usage). Patient had the following side effects: hyperhidrosis, insomnia, night sweats, sleep apnoea syndrome. Kenalog dosage: .

6921859-X | Maculopathy
on Aug 06, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with macular oedema and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: maculopathy. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6921856-4 | Maculopathy
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: maculopathy on Aug 06, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with macular oedema and. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6921852-7 | Maculopathy
Adverse event was reported on Aug 06, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: 1 Df = 4mg/0.1ml, Injection) was diagnosed with macular oedema and. Location: UNITED STATES , 59 years of age, Patient had the following side effects: maculopathy.

6921850-3 | Maculopathy
on Aug 06, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with macular oedema and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: maculopathy. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection; 2 Injections.

6921849-7 | Maculopathy
on Aug 06, 2010 Male patient from UNITED STATES , 57 years of age, was diagnosed with macular oedema and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: maculopathy. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6921847-3 | Maculopathy
Patient was taking Kenalog (View Usage). Patient had the following side effects: maculopathy on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with macular oedema and. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6921836-9 | Maculopathy
Adverse event was reported on Aug 06, 2010 by a Male patient taking Kenalog (View Usage) (Dosage: 1 Df = 4mg/0.1ml, Injection) was diagnosed with retinal vein occlusion and. Location: UNITED STATES , 72 years of age, After Kenalog was administered, patient had the following side effects: maculopathy.

6921830-8 | Maculopathy
on Aug 06, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with macular oedema and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: maculopathy. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6921825-4 | Maculopathy
on Aug 06, 2010 Female patient from UNITED STATES , 62 years of age, was diagnosed with macular oedema and was treated with Kenalog (View Usage). Patient had the following side effects: maculopathy. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6921822-9 | Maculopathy
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: maculopathy on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with macular oedema and. Kenalog dosage: 1 Df = 4mg/0.1ml, Injection.

6911354-6 | Anxiety, Injection Site Atrophy, Muscle Atrophy, Pain, Weight Decreased
Adverse event was reported on Aug 02, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), injection site atrophy, muscle atrophy, pain (What is pain?), weight decreased.

6771360-1 | Intracranial Hypotension, Meningeal Neoplasm
on Jun 09, 2010 Female patient from UNITED STATES , 39 years of age, was treated with Kenalog (View Usage). Patient had the following side effects: intracranial hypotension, meningeal neoplasm. Kenalog dosage: Dose Range: 60-80 Mg, Each At 2 Week Intervals. During the same period patient was treated with LIDOCAINE 2% (View Lidocaine 2% Review and Lidocaine 2% Label ). Patient was hospitalized.

6771334-0 | Central Nervous System Mass, Headache, Intracranial Hypotension, Neck Pain, Night Sweats
on Jun 09, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with intervertebral disc displacement and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: central nervous system mass, headache (What is headache?), intracranial hypotension, neck pain, night sweats. Kenalog dosage: Dose Range: 60-80 Mg. During the same period patient was treated with LIDOCAINE 2% (View Lidocaine 2% Review and Lidocaine 2% Label ). Patient was hospitalized and became disabled.

6744476-3 | Cellulitis, Injection Site Discolouration, Injection Site Pain
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), injection site discolouration, injection site pain on May 24, 2010 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with granuloma annulare and. Kenalog dosage: Via Dermojet Injection. During the same period patient was treated with CUTIVATE (Cutivate Lotion X 4 Wks) (View Cutivate Review and Cutivate Label ).

6738983-7 | Injection Site Haematoma, Injection Site Induration, Injection Site Reaction, Musculoskeletal Pain, Skin Discolouration
Adverse event was reported on May 24, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: Kenalog 10mg, 30mg, 20 Mg Sq) was diagnosed with hypersensitivity and. Location: UNITED STATES , 32 years of age, weighting 128.0 lb, Patient had the following side effects: injection site haematoma, injection site induration, injection site reaction, musculoskeletal pain, skin discolouration.

6736466-1 | Adrenal Suppression, Back Pain, Depression, Fatigue, Suicidal Ideation, Weight Increased
on Mar 30, 2010 Female patient from UNITED STATES , 33 years of age, weighting 125.7 lb, was diagnosed with back pain (What is back pain?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: adrenal suppression, back pain (What is back pain?), depression (What is depression?), fatigue, suicidal ideation, weight increased. Kenalog dosage: 11/2007. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), METHADONE (View Methadone Review and Methadone Label ), PERCOCET (View Percocet Review and Percocet Label ), NEXIUM (View Nexium Review and Nexium Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ORTHO TRI CYCLEN (View Ortho Tri-cyclen Review and Ortho Tri-cyclen Label ).

6730789-8 | Cellulitis, Injection Site Discolouration, Injection Site Pain
on May 13, 2010 Female patient from UNITED STATES , 42 years of age, was diagnosed with granuloma annulare and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), injection site discolouration, injection site pain. Kenalog dosage: Via Dermojet Injection.

6715989-5 | Discomfort, Injection Site Reaction, Pain, Skin Discolouration, Skin Disorder
Patient was taking Kenalog (View Usage). Patient had the following side effects: discomfort, injection site reaction, pain (What is pain?), skin discolouration, skin disorder on May 06, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, weighting 115.0 lb, . Kenalog dosage: .

6701859-5 | Blood Glucose Increased, Vaginal Haemorrhage
Adverse event was reported on Apr 27, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: Epidural Injection Also Received On 05apr2010 Kenalog 80mg Inj Into The Knee) was diagnosed with back pain (What is back pain?), arthritis (What is arthritis?), meniscus lesion and. Location: UNITED STATES , 56 years of age, weighting 249.1 lb, After Kenalog was administered, patient had the following side effects: blood glucose increased, vaginal haemorrhage. During the same period patient was treated with BENICAR (View Benicar Review and Benicar Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6699029-2 | Choroidal Infarction, Retinal Infarction, Visual Acuity Reduced
on Apr 20, 2010 Female patient from ITALY , 86 years of age, was diagnosed with choroidal neovascularisation and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal infarction, retinal infarction, visual acuity reduced. Kenalog dosage: 1 Df = 4mg In 0.1ml Of Saline. Roa- Intravitreal. During the same period patient was treated with VERTEPORFIN (View Verteporfin Review and Verteporfin Label ).

6698323-9 | Anxiety, Injection Site Atrophy, Menorrhagia, Nausea
on Apr 26, 2010 Female patient from UNITED STATES , 32 years of age, weighting 175.0 lb, was diagnosed with urticaria and was treated with Kenalog (View Usage). Patient had the following side effects: anxiety (What is anxiety?), injection site atrophy, menorrhagia, nausea (What is nausea?). Kenalog dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ).

6687698-2 | Blood Glucose Increased, Vaginal Haemorrhage
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: blood glucose increased, vaginal haemorrhage on Apr 15, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 249.1 lb, was diagnosed with back pain (What is back pain?), arthritis (What is arthritis?), meniscus lesion and. Kenalog dosage: Epidural Injection Also Received On 05apr2010 Kenalog 80mg Inj Into The Knee. During the same period patient was treated with BENICAR (View Benicar Review and Benicar Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6680936-1 | Arthralgia, Arthropathy, Crying, Deformity, Depression, Dizziness, Erythema, Feeling Abnormal, Headache
Adverse event was reported on Apr 13, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: 10 Mg Once Im) was diagnosed with epicondylitis and. Location: UNITED STATES , weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, arthropathy, crying, deformity, depression (What is depression?), dizziness (What is dizziness?), erythema, feeling abnormal, headache (What is headache?).

6591157-5 | Vaginal Haemorrhage
on Nov 20, 2009 Female patient from UNITED STATES , 45 years of age, weighting 134.5 lb, was treated with Kenalog (View Usage). Patient had the following side effects: vaginal haemorrhage. Kenalog dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

6591155-1 | Injection Site Pain
on Dec 15, 2009 Male patient from UNITED STATES , 51 years of age, was diagnosed with hypersensitivity and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site pain. Kenalog dosage: . During the same period patient was treated with PRAVACHOL (View Pravachol Review and Pravachol Label ), DILANTIN (View Dilantin Review and Dilantin Label ), CELEXA (View Celexa Review and Celexa Label ), ASTELIN (View Astelin Review and Astelin Label ), MUCINEX (View Mucinex Review and Mucinex Label ).

6591154-X | Injection Site Pain
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site pain on Dec 15, 2009 from UNITED STATES Additional patient health information: Female patient , 50 years of age, was diagnosed with hypersensitivity and. Kenalog dosage: 40mg/m.l/10m.l.

6591153-8 | Agitation, Anxiety, Injection Site Pain, Injection Site Pruritus, Insomnia
Adverse event was reported on Oct 22, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: ) was diagnosed with nodule and. Location: UNITED STATES , 51 years of age, weighting 136.7 lb, Patient had the following side effects: agitation, anxiety (What is anxiety?), injection site pain, injection site pruritus, insomnia. During the same period patient was treated with ADVIL (View Advil Review and Advil Label ).

6591150-2 | Oedema Peripheral, Purpura, Swelling Face
on Sep 11, 2009 Female patient from UNITED STATES , 74 years of age, weighting 112.4 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: oedema peripheral, purpura, swelling face. Kenalog dosage: 2nd Injection On 5may09 120mg:05may09. During the same period patient was treated with LIDOCAINE (Lidocaine 1% Plain 5cc In Each Injection 2nd Inj On 5may2009) (View Lidocaine Review and Lidocaine Label ), PREMARIN (View Premarin Review and Premarin Label ), XALATAN (View Xalatan Review and Xalatan Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6591145-9 | Injection Site Atrophy
on Jul 06, 2009 Female patient from UNITED STATES , 30 years of age, weighting 114.6 lb, was diagnosed with hypersensitivity and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site atrophy. Kenalog dosage: 1 Cc.

6591141-1 | Anaemia, Injection Site Atrophy, Nausea, Vaginal Haemorrhage
Patient was taking Kenalog (View Usage). Patient had the following side effects: anaemia, injection site atrophy, nausea (What is nausea?), vaginal haemorrhage on Jun 04, 2009 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 154.3 lb, was diagnosed with intervertebral disc protrusion and. Kenalog dosage: .

6591132-0 | Rash Erythematous
Adverse event was reported on Mar 26, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: ) was diagnosed with rash macular and. Location: UNITED STATES , 62 years of age, weighting 156.5 lb, After Kenalog was administered, patient had the following side effects: rash erythematous. During the same period patient was treated with STEROID CREAM (View Steroid Cream Review and Steroid Cream Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ).

6591130-7 | Chest Discomfort, Dizziness, Pruritus, Urticaria
on Mar 16, 2009 Female patient from UNITED STATES , 70 years of age, weighting 196.2 lb, was diagnosed with rotator cuff syndrome and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, dizziness (What is dizziness?), pruritus, urticaria. Kenalog dosage: Injection Was Received On 22dec08.. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), CADUET (View Caduet Review and Caduet Label ).

6591126-5 | Chromaturia, Gait Disturbance, Headache, Heart Rate Increased, Hip Fracture, Micturition Disorder, Nausea, Nervousness, Oedema Peripheral
on Jan 20, 2009 Female patient from UNITED STATES , 53 years of age, weighting 185.2 lb, was diagnosed with skin ulcer and was treated with Kenalog (View Usage). Patient had the following side effects: chromaturia, gait disturbance, headache (What is headache?), heart rate increased, hip fracture, micturition disorder, nausea (What is nausea?), nervousness, oedema peripheral. Kenalog dosage: 80mg Every 2-3 Weeks.. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), VALTREX (View Valtrex Review and Valtrex Label ).

6591125-3 | Injection Site Atrophy, Injection Site Discolouration, Insomnia, Pain
Patient was taking Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site atrophy, injection site discolouration, insomnia, pain (What is pain?) on Jan 12, 2009 from UNITED STATES Additional patient health information: Female patient , 22 years of age, weighting 119.0 lb, was diagnosed with influenza and. Kenalog dosage: . During the same period patient was treated with DEXAMETHASONE (Taken As Injection) (View Dexamethasone Review and Dexamethasone Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

6527467-7 | Injection Site Discolouration, Injection Site Induration, Menorrhagia, Weight Decreased
Adverse event was reported on Jan 04, 2010 by a Female patient taking Kenalog (View Usage) (Dosage: ) was diagnosed with allergy to animal, seasonal allergy and. Location: UNITED STATES , 30 years of age, weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: injection site discolouration, injection site induration, menorrhagia, weight decreased.

6522413-4 | Emotional Disorder, Injection Site Discolouration, Injection Site Dryness, Injection Site Induration
on Dec 29, 2009 Female patient from UNITED STATES , 23 years of age, weighting 110.0 lb, was treated with Kenalog (View Usage). Patient had the following side effects: emotional disorder, injection site discolouration, injection site dryness, injection site induration. Kenalog dosage: One Shot Once.

6444434-2 | Injection Site Discolouration, Injection Site Induration, No Therapeutic Response, Procedural Site Reaction, Skin Discolouration, Skin Induration
on Nov 17, 2009 Female patient from UNITED STATES , 42 years of age, weighting 105.0 lb, was diagnosed with scar (What is scar?) and was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: injection site discolouration, injection site induration, no therapeutic response, procedural site reaction, skin discolouration, skin induration. Kenalog dosage: 5mg Three Times Id.

6419024-8 | Contusion
Patient was taking Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: contusion on Oct 28, 2009 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 125.0 lb, was diagnosed with eczema (What is eczema?) and. Kenalog dosage: .

6411796-1 | Corneal Disorder
Adverse event was reported on Oct 21, 2009 by a Female patient taking Kenalog (View Usage) (Dosage: Kenalog Unfiltered;1 Dosage Form=40mg/ml.) . Location: SINGAPORE , 60 years of age, Patient had the following side effects: corneal disorder.

6408461-3 | Corneal Disorder
on Oct 19, 2009 Female patient from SINGAPORE , 60 years of age, was treated with Kenalog (View Usage). After Kenalog was administered, patient had the following side effects: corneal disorder. Kenalog dosage: Kenalog Unfiltered;1 Dosage Form=40mg/ml..

6388324-2 | Injection Site Atrophy
on Oct 01, 2009 Female patient from UNITED STATES , 29 years of age, weighting 130.0 lb, was diagnosed with injection site reaction and was treated with Kenalog (View Usage). Patient experienced the following unwanted or unexpected effects: injection site atrophy. Kenalog dosage: 40 Mg/ml Once Im Once.

6368665-5 | Injection Site Atrophy, Injection Site Reaction, Injection Site Ulcer, Skin Discolouration
Patient was taking Kenalog (View Usage). Patient had the following side effects: injection site atrophy, injection site reaction, injection site ulcer, skin discolouration on Sep 19, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 100.0 lb, . Kenalog dosage: 40mg Once Im.